Physician profile
Justin Ratcliffe
NPI 1770747123
$136,563.71
in general payments reported to CMS, 2019-2025
10 companies · $31K in 2025
The $31K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $31.73 · 2021: $306 · 2022: $13K · 2023: $59K · 2024: $34K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $90K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,225 · Consulting Fee: $4,200 · Food and Beverage: $1,952 · Travel and Lodging: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $90,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,100.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,225.00 |
| Consulting Fee | $4,200.00 |
| Food and Beverage | $1,951.66 |
| Travel and Lodging | $841.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $95,171.35 | 2022-2025 | Auryon Laser System 100-120 Vac, Angiovac, Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $22,324.28 | 2019-2025 | Diamondback Peripheral, Absolute Pro, Diamondback Coronary |
| Cardiovascular Systems INC. | $17,522.47 | 2019-2023 | Diamondback Peripheral |
| Siemens Medical Solutions USA, INC. | $930.56 | 2022-2025 | Cios Alpha |
| Heartflow, INC. | $302.76 | 2021-2023 | Ffrct |
| Astrazeneca Pharmaceuticals Lp | $161.09 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $87.49 | 2021 | |
| Novartis Pharmaceuticals Corporation | $35.85 | 2019-2022 | |
| Boston Scientific Corporation | $27.86 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Ratcliffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.